Compounds which have utility in the treatment of conditions associated with altered mitochondrial function. The compounds have the following structure (I): ##STR1##

including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.

 
Web www.patentalert.com

< C-aryl glucoside SGLT2 inhibitors and method

< Piperidine-piperazine ligands for neurotransmitter receptors

> Active agent delivery systems and methods for protecting and administering active agents

> Imidazonline compounds

~ 00203